Viviscal Clinical Studies

clinical_trialsThere have been numerous studies conducted on Viviscal over the last 22 years (we have 11 although there may be more). Here is a summery of the more significant ones:

1. A comparative study of a new food Supplement, Viviscal , containing marine derived polysaccharide, with Fish extract for the treatment of Hereditary Androgenic Alopecia in young males

  • By: Lassus & E.Eskelinen
  • Date published: 1992 (The Journal of International Medical Research)
  • Number of participants: 40 males
  • Double blind
  • Placebo controlled

Results:

  • All of the participants said that their hair loss stopped after using Viviscal for 2 months.
  • Average hair count increased by 38% over 6 months

The study concluded that the marine complex appeared to be a very effective treatment of androgenic alopecia in young men.

2. Treatment of Androgenic Alopecia with a marine-based Extract.

  • By: Jose Marcos Pereira.
  • Date published: 1997 (Revista Brasileira de Medicina.)
  • Number of participants: 200 males

Results:

  • Over three quarters of the subjects showed a big reduction in their hair loss.
  • 14.6% of participants experienced some regrowth of hair.

The results of the study indicate that the marine based extract is beneficial for those suffering from androgenic alopecia. The earlier treatment starts the more likely it will have an effect.

3. Treatment of Androgenic Alopecia with a marine-based Extract (Viviscal).

  • By: E. Thom
  • Date published: 2001 (The Journal of International Medical Research)
  • Number of participants: 55 males 5 females
  • Double blind
  • Placebo controlled

Results:

  • After six months treatment subjects showed and average 32.4 increase in hair growth
  • After twelve months this figure increased to 63.9%

4. A Double-blind study of Nourkrin with placebo to investigate the effect and tolerability in persons with hair loss.

  • By: E. Thom
  • Date published: 2006 (The Journal of International Medical Research)
  • Number of participants: 51 males 4 females
  • Double blind
  • Placebo controlled

Results:

  • After six months the average hair count had increased by 35.7%
  • After twelve months the hair count had increased by 61.5%

Participants reported excellent tolerability as well as an overall positive effect on their hair.

5. Abstract: Double-blind, Placebo-controlled Clinical Trial Of Viviscal

  • By: Thomas J. Stephens & Associates
  • Date published: 2013 (7th World Congress for Hair Research)
  • Number of participants: 72 females
  • Double blind
  • Placebo controlled

Results after six months:

  • There was an average of 18.3% reduction in the shedding of hair
  • A 7.4% increase in the thickness of the participants hair

Participants reported excellent tolerability as well as an overall positive effect on their hair.

Other clinical trials.

There have been a few more Viviscal clinical studies which we have not included here due to the trial size or quality (not being double blind or placebo controlled) as well as one which is currently ongoing at the time of writing this (2014) we will include it once it is published.

Save